ASB4 p.Glu116Lys
c.346G>A · VCV4152559
Computational evidence
| Protein change | ||
| AlphaMissense | 0.612 | likely pathogenic |
|---|---|---|
| REVEL | 0.231 | benign-leaning |
| SaProt | LLR -7.16 | tolerated |
| ⇒ AlphaMissense calls this damaging; REVEL and SaProt do not. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 9.8 | GERP 2.3, phastCons 1 |
| Regional constraint | o/e 1.06 | unconstrained · MANE · 52 kb · p 0.19 · regional, not allelic |
| Overall | ||
| CADD | 23.8 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| South Asiangrpmax | 0.11% | 911 |
| Middle Eastern | 0.0825% | 1,212 |
| Remaining individualsnot grpmax-eligible | 0.0032% | 31,253 |
| East Asian | 0.00223% | 44,868 |
| European (non-Finnish) | 0.00144% | 69,413 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- ASB4
- Protein
- p.Glu116Lys
- Coding
- c.346G>A
- MANE Select
- NM_016116
- Type
- single nucleotide variant
- Location
- chr7:95495916 (GRCh38)
- Gene constraint
- LOEUF 1.226 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 92.69
Similar variants
- ASB4 p.Ala13Thr Uncertain significance ★ ⚠ same type
- ASB4 p.Ala156Ser Uncertain significance ★ ⚠ same type
- ASB4 p.Ala182Thr Uncertain significance ★ ⚠ same type
- ASB4 p.Ala206Val Uncertain significance ★ ⚠ same type
- ASB4 p.Ala35Ser Uncertain significance ★ ⚠ same type
- ASB4 p.Ala58Thr Uncertain significance ★ ⚠ same type
- ASB4 p.Ala6Asp Uncertain significance ★ ⚠ same type
- ASB4 p.Arg236Cys Uncertain significance ★ ⚠ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/asb4-p-glu116lys (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown